Refine
Year of publication
Document Type
- Article (15199)
- Part of Periodical (2805)
- Working Paper (2336)
- Doctoral Thesis (2007)
- Book (1737)
- Preprint (1712)
- Part of a Book (1055)
- Conference Proceeding (733)
- Report (471)
- Review (165)
Language
- English (28409) (remove)
Keywords
- taxonomy (715)
- new species (430)
- morphology (169)
- Deutschland (141)
- Syntax (125)
- Englisch (120)
- distribution (111)
- Deutsch (98)
- biodiversity (96)
- inflammation (95)
Institute
- Medizin (5138)
- Physik (3422)
- Wirtschaftswissenschaften (1881)
- Frankfurt Institute for Advanced Studies (FIAS) (1551)
- Biowissenschaften (1481)
- Center for Financial Studies (CFS) (1472)
- Informatik (1364)
- Biochemie und Chemie (1063)
- Sustainable Architecture for Finance in Europe (SAFE) (1045)
- House of Finance (HoF) (699)
Background: Treatment options for poorly differentiated (PDTC) and anaplastic (ATC) thyroid carcinoma are unsatisfactory and prognosis is generally poor. Lenvatinib (LEN), a multi-tyrosine kinase inhibitor targeting fibroblast growth factor receptors (FGFR) 1-4 is approved for advanced radioiodine refractory thyroid carcinoma, but response to single agent is poor in ATC. Recent reports of combining LEN with PD-1 inhibitor pembrolizumab (PEM) are promising. Materials and Methods: Primary ATC (n=93) and PDTC (n=47) tissue samples diagnosed 1997-2019 at five German tertiary care centers were assessed for PD-L1 expression by immunohistochemistry using Tumor Proportion Score (TPS). FGFR 1-4 mRNA was quantified in 31 ATC and 14 PDTC with RNAscope in-situ hybridization. Normal thyroid tissue (NT) and papillary thyroid carcinoma (PTC) served as controls. Disease specific survival (DSS) was the primary outcome variable. Results: PD-L1 TPS≥50% was observed in 42% of ATC and 26% of PDTC specimens. Mean PD-L1 expression was significantly higher in ATC (TPS 30%) than in PDTC (5%; p<0.01) and NT (0%, p<0.001). 53% of PDTC samples had PD-L1 expression ≤5%. FGFR mRNA expression was generally low in all samples but combined FGFR1-4 expression was significantly higher in PDTC and ATC compared to NT (each p<0.001). No impact of PD-L1 and FGFR 1-4 expression was observed on DSS. Conclusion: High tumoral expression of PD-L1 in a large proportion of ATCs and a subgroup of PDTCs provides a rationale for immune checkpoint inhibition. FGFR expression is low thyroid tumor cells. The clinically observed synergism of PEM with LEN may be caused by immune modulation.
FIAS Scientific Report
(2011)
FIAS Scientific Report 2009
(2010)
In this Annual Report we present some of the ongoing activities of FIAS and of the associated graduate
school, the “Frankfurt International Graduate School for Science” (FIGSS) in the year 2009. The main part of the Report consists of a collection of short reports describing the research projects of scientists working at or associated with FIAS.
FIAS Scientific Report 2010
(2011)
In the year 2010 the Frankfurt Institute for Advanced Studies has successfully continued to follow its agenda to pursue theoretical research in the natural sciences. As stipulated in its charter, FIAS closely collaborates with extramural research institutions, like the Max Planck Institute for Brain Research in Frankfurt and the GSI Helmholtz Center for Heavy Ion Research, Darmstadt and with research groups at the science departments of Goethe University. The institute also engages in the training of young researchers and the education of doctoral students. This Annual Report documents how these goals have been pursued in the year 2010. Notable events in the scientific life of the Institute will be presented, e.g., teaching activities in the framework of the Frankfurt International Graduate School for Science (FIGSS), colloquium schedules, conferences organized by FIAS, and a full bibliography of publications by authors affiliated with FIAS. The main part of the Report consists of short one-page summaries describing the scientific progress reached in individual research projects in the year 2010...
FIAS Scientific Report 2011
(2012)
FIAS Scientific Report 2012
(2013)
FIAS Scientific Report 2013
(2014)
FIAS Scientific Report 2014
(2015)
Cardiac fibroblasts constitute a major cell population in the heart. They secrete extracellular matrix components and various other factors shaping the microenvironment of the heart. In silico analysis of intercellular communication based on single-cell RNA sequencing revealed that fibroblasts are the source of the majority of outgoing signals to other cell types. This observation suggests that fibroblasts play key roles in orchestrating cellular interactions that maintain organ homeostasis but that can also contribute to disease states. Here, we will review the current knowledge of fibroblast interactions in the healthy, diseased, and aging heart. We focus on the interactions that fibroblasts establish with other cells of the heart, specifically cardiomyocytes, endothelial cells and immune cells, and particularly those relying on paracrine, electrical, and exosomal communication modes.